View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Nanobiotix: 1 director

A director at Nanobiotix bought 1,100 shares at 26.618USD and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...

 PRESS RELEASE

Haffner Energy launches CORE100, an industrial program with over €300 ...

Haffner Energy launches CORE100, an industrial program with over €300 million target sales over three years Vitry-le-François, February 18, 2026 – 6:00 p.m. (CET) Haffner Energy today announces the launch of CORE100, a reservation program for 100 standardized C-iC industrial units, representing a target business volume of over €300 million over three years. This program is expected to enable Haffner Energy to achieve positive EBITDA in the fiscal year beginning April 1, 2026, with a target EBITDA margin of more than 10% as of the following fiscal year. The Company anticipates being able ...

 PRESS RELEASE

Haffner Energy ouvre CORE100, un programme industriel de réservation d...

Haffner Energy ouvre CORE100, un programme industriel de réservation de plus de 300 millions d’euros de ventes sur trois ans Vitry-le-François, le 18 février 2026 – 18h00 (CET) Haffner Energy annonce aujourd’hui l’ouverture de CORE100, un programme de réservation portant sur 100 unités industrielles standardisées C-iC, représentant un volume d’activité cible supérieur à 300 millions d’euros sur trois ans. Ce programme devrait permettre à Haffner Energy d’atteindre un EBITDA positif dès l’exercice débutant le 1er avril 2026, avec un objectif de marge d’EBITDA supérieure à 10% dès l’exerci...

Carole Braudeau
  • Carole Braudeau

Credit Morning 02/18/2026

Tereos : -57% EBITDA over 9M 25/26. Guidance reaffirmed for a leverage peak at 6x as of March 31|Celanese – still challenging conditions but margins and FCF generation remain healthy|Emeis reported 2025 results ahead of expectations|

Carole Braudeau
  • Carole Braudeau

Morning Crédit 18/02/2026

Tereos : -57% d’EBITDA sur les 9M 25/26. Prévision réitérée d’un pic de levier à 6x au 31 mars|Celanese – still challenging conditions but margins and FCF generation remain healthy|Emeis a publié des résultats 2025 supérieurs aux attentes|

Christophe-Raphaël Ganet
  • Christophe-Raphaël Ganet
Christophe-Raphaël Ganet
  • Christophe-Raphaël Ganet
 PRESS RELEASE

Information mensuelle relative au nombre total de droits de vote et d...

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers PARIS, 17 févr. 2026 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Paris / NasdaqEuronext Compartiment : B Code ISIN : FR0011341205Nasdaq : NBTXBloomberg : NANO:FPReuters : NANO.PASite web : DateNombre total d’actions composant le capital socialNombre total de droits de voteTotal théorique1Total exerçable231 janvier 202648 450 35850 153 46050 131 342 À pr...

 PRESS RELEASE

Voting Rights and Shares Capital of the Company

Voting Rights and Shares Capital of the Company In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Market: Euronext Paris / NasdaqEuronext Compartment: B ISIN code: FR0011341205Nasdaq: NBTXBloomberg: NANO:FPReuters: NANO.PAWebsite: DateNumber of Shares OutstandingTotal number of voting rightsTotal voting rights, theoretical1Total voting rights, exercisable2January 31, 202648,450,35850,153,46050,131,342 About NANOBIOTI...

Benoit Valleaux ... (+2)
  • Benoit Valleaux
  • Steven Gould

Intesa Sanpaolo : New medium-term strategic plan: when 'continuity' ma...

The announcement in early February of the new medium-term strategic plan (2026-2029) bolstered our Outperform rating on ISP (TP raised to € 7.0 from € 6.4), one of our sector top picks. In short, when the strategy is right, continuity has its virtues! Although ISP is lagging behind the sector in terms of re-rating, its valuation remains attractive given its fundamentals and outlook (RoE +4pp to 18% by 2029e, total return of 12% vs 6% for the sector).

Benoit Valleaux ... (+2)
  • Benoit Valleaux
  • Steven Gould

Intesa Sanpaolo : Nouveau plan stratégique MT : quand la ‘continuité’ ...

L’annonce, début février, du nouveau plan stratégique MT (2026-29) a renforcé notre opinion Surperformance sur ISP (OC porté à 7.0 € vs 6.4 €), l’un de nos top picks sectoriels. En un mot, quand une stratégie est bonne, la continuité a des vertus ! Alors qu’ISP est à la traîne en termes de rerating vs secteur, la valorisation reste intéressante au regard des fondamentaux et des perspectives (RoE +4pp à 18% d’ici 2029e, total return de 12% vs 6% pour secteur).

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch